Skip to main content
Leukemia Research Reports logoLink to Leukemia Research Reports
. 2022 Apr 6;17:100309. doi: 10.1016/j.lrr.2022.100309

Erratum regarding missing informed consent statements in previously published articles

PMCID: PMC9271497  PMID: 35832056

Informed consent was not included in the published version of the following articles that appeared in previous issues of Leukemia Research Reports. Hence, the authors of the below articles were contacted after publication to request an informed consent but have not responded by the time this erratum is being published:

  • 1

    “Sustained MRD negative remission in del17p and TP53 mutated B cell prolymphocytic leukemia with ibrutinib and venetoclax” [Leukemia Research Reports, 2021; 16C: 100266] 10.1016/j.lrr.2021.100266

  • 2

    “Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome” [Leukemia Research Reports, 2021; 16C: 100274] 10.1016/j.lrr.2021.100274

  • 3

    “Pediatric M5 acute myeloid leukemia with MLL-SEPT6 fusion and a favorable outcome” [Leukemia Research Reports, 2021; 16C: 100277] 10.1016/j.lrr.2021.100277

  • 4

    “Successful allogeneic bone marrow transplantation after massive gastrointestinal bleeding in a patient with myelodysplastic syndrome associated with intestinal Behçet-like disease” [Leukemia Research Reports, 2021; 16C: 100278] 10.1016/j.lrr.2021.100278

  • 5

    “Successful treatment with ABL tyrosine kinase inhibitor for patients with acute myeloid leukemia with BCR-ABL1” [Leukemia Research Reports, 2021;15C: 100233] 10.1016/j.lrr.2020.100233

  • 6

    “De-novo acute myeloid leukemia in a BRCA positive female with locally treated ductal carcinoma In Situ” [Leukemia Research Reports, 2021;15C: 100237] 10.1016/j.lrr.2021.100237

  • 7

    “Amyloid arthropathy in smoldering myeloma: Do not take it lightly” [Leukemia Research Reports, 2021;15C: 100242] 10.1016/j.lrr.2021.100242

  • 8

    “An unusual case of chronic lymphocytic leukemia with trisomy 12 and t(14;18) and a favorable response to ibrutinib” [Leukemia Research Reports, 2021;15C: 100245] 10.1016/j.lrr.2021.100245

  • 9

    “Intravascular large B-cell lymphoma as a recurrence of primary central nervous system lymphoma after chemotherapy: A case report” [Leukemia Research Reports, 2021;15C: 100249] 10.1016/j.lrr.2021.100249

  • 10

    “Acute myeloid leukemia with hepatic infiltration presenting as obstructive jaundice” [Leukemia Research Reports, 2021;15C: 100251] 10.1016/j.lrr.2021.100251

  • 11

    “Distal chromosome 1q aberrations and initial response to ibrutinib in central nervous system relapsed mantle cell lymphoma” [Leukemia Research Reports, 2021;15C: 100255] 10.1016/j.lrr.2021.100255

  • 12

    “New translocation in acute myeloid leukemia M4 eos” [Leukemia Research Reports, 2020; 14C: 100209] 10.1016/j.lrr.2020.100209

  • 13

    “Even mild hemolysis in paroxysmal nocturnal hemoglobinuria could severely compromise the quality of life due to long-term sustained intolerant fatigue” [Leukemia Research Reports, 2020; 14C: 100224] 10.1016/j.lrr.2020.100224

  • 14

    “Myasthenia Gravis and Large Granular Lymphocytic Leukemia: a rare association” [Leukemia Research Reports, 2020; 14C: 100226] 10.1016/j.lrr.2020.100226

  • 15

    “Focal blast crisis in concomitant myelodysplastic syndrome and chronic myelogenous leukemia” [Leukemia Research Reports, 2020; 14C: Leukemia Research Reports, 2020; 14C] 10.1016/j.lrr.2020.100225


Articles from Leukemia Research Reports are provided here courtesy of Elsevier

RESOURCES